経カテーテル大動脈弁置換 (TAVR)/留置 (TAVI)：市場洞察・競合環境・市場予測 (～2030年)

経カテーテル大動脈弁置換 (TAVR) デバイスの市場規模は、2023年の28億米ドルから、2024年から2030年にかけての予測期間中はCAGR 15.41％で推移し、2030年には66億米ドルの規模に成長すると予測されています。

TAVRデバイス市場は、大動脈弁狭窄症、大動脈弁閉鎖不全症、僧帽弁閉鎖不全症などの慢性疾患の事例の増加、製品の発売を含む製品開発活動の増加、高齢者人口の増加などの要因によって大きく成長しています。

TAVRデバイス市場の力学：

The National Institute of Healthの2022年のデータによれば、大動脈弁狭窄症は先進国でもっとも一般的に発生する弁膜症であり、世界で平均900万人が罹患しており、その有病率は高齢化とアテローム性動脈硬化症の増加に伴って増加していると報告されています。大動脈弁閉鎖不全症は、収縮期高血圧ではなく拡張期高血圧と関連しており、同様に先進諸国で増加しています。僧帽弁閉鎖不全症は全世界で2,400万人が罹患しており、国によって大きなばらつきがあります。

TAVRは弁膜症、特に大動脈弁狭窄症の治療において極めて重要です。これらの疾患はしばしば加齢や関連する健康問題と関連しているため、TAVRは従来の手術に耐えられないような高リスクの患者に低侵襲の解決策を提供します。より短い回復時間で効果的な弁置換を可能にすることで、TAVRは、人口の高齢化と動脈硬化率の上昇に直面して、大動脈および関連する弁病変に対するアクセス可能な高度治療に対するニーズの高まりに対応しています。

北米は経カテーテル大動脈弁置換装置市場全体を支配すると予想される：

すべての地域の中で、北米が経カテーテル大動脈弁置換装置市場で大きな収益シェアを占めると推計されています。これは、大動脈弁狭窄症の負担の増加、規制支援、迅速かつ確立されたヘルスケアサービスやインフラ、主要プレイヤーの存在、および2024年から2030年にかけて北米の経カテーテル大動脈弁置換デバイスの市場成長を大幅に推進すると予想されるその他の要因によるものです。

当レポートでは、世界の経カテーテル大動脈弁置換 (TAVR)/植え込み (TAVI) の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 経カテーテル大動脈弁置換 (TAVR) デバイス市場：イントロダクション

第2章 経カテーテル大動脈弁置換 (TAVR) デバイス市場：エグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 経カテーテル大動脈弁置換 (TAVR) デバイス市場：主要要因分析

• 市場促進要因
  • 慢性疾患の増加
  • 世界的な製品開発活動の拡大
  • 高齢化人口の増加
• 市場抑制要因・課題
  • 出血、血腫、血管損傷などの副作用
  • 代替オプションのアベイラビリティ
• 市場機会
  • 改良された耐久性のある生体弁の開発
  • 精度に関連するAIとロボット支援の統合

第6章 経カテーテル大動脈弁置換 (TAVR) デバイス市場：ポーターのファイブフォース分析

第7章 経カテーテル大動脈弁置換 (TAVR) デバイス市場：市場評価

• 材料別
  • バルブフレーム材料
  • 弁尖材料
• 処置別
  • 経大腿アプローチ
  • 経心尖アプローチ
  • 経大動脈アプローチ
• 用途別
  • 大動脈弁狭窄症
  • 大動脈弁逆流症
  • その他
• エンドユーザー別
  • 病院
  • 外来手術センター
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 経カテーテル大動脈弁置換 (TAVR) デバイス市場：企業・製品プロファイル

• Medtronic
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• Meril Life Sciences
• Abbott
• JenaValve Technology, Inc.
• Bracco SpA
• CryoLife, Inc.
• Braile Biomedica
• Venus Medtech
• Transcatheter Technologies Gmbh
• Thubrikar Aortic Valve
• Blue Sail Medical Co. Ltd.
• JC Medical Inc.
• Cook
• Sysmetis SA
• SMT Pvt Ltd.
• LivaNova
• Peijia Medical
• P+F Products + Features GmbH

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項・お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Transcatheter Aortic Valve Replacement Devices Market in Global (2021-2030)
• Table 3: Transcatheter Aortic Valve Replacement Devices Market in Global by Material (2021-2030)
• Table 4: Transcatheter Aortic Valve Replacement Devices Market in Global by Procedure (2021-2030)
• Table 5: Transcatheter Aortic Valve Replacement Devices Market in Global by Application (2021-2030)
• Table 6: Transcatheter Aortic Valve Replacement Devices Market in Global by End-User (2021-2030)
• Table 7: Transcatheter Aortic Valve Replacement Devices Market in Global by Geography (2021-2030)
• Table 8: Transcatheter Aortic Valve Replacement Devices Market in North America (2021-2030)
• Table 9: Transcatheter Aortic Valve Replacement Devices Market in the United States (2021-2030)
• Table 10: Transcatheter Aortic Valve Replacement Devices Market in Canada (2021-2030)
• Table 11: Transcatheter Aortic Valve Replacement Devices Market in Mexico (2021-2030)
• Table 12: Transcatheter Aortic Valve Replacement Devices Market in Europe (2021-2030)
• Table 13: Transcatheter Aortic Valve Replacement Devices Market in France (2021-2030)
• Table 14: Transcatheter Aortic Valve Replacement Devices Market in Germany (2021-2030)
• Table 15: Transcatheter Aortic Valve Replacement Devices Market in United Kingdom (2021-2030)
• Table 16: Transcatheter Aortic Valve Replacement Devices Market in Italy (2021-2030)
• Table 17: Transcatheter Aortic Valve Replacement Devices Market in Spain (2021-2030)
• Table 18: Transcatheter Aortic Valve Replacement Devices Market in the Rest of Europe (2021-2030)
• Table 19: Transcatheter Aortic Valve Replacement Devices Market in Asia-Pacific (2021-2030)
• Table 20: Transcatheter Aortic Valve Replacement Devices Market in China (2021-2030)
• Table 21: Transcatheter Aortic Valve Replacement Devices Market in Japan (2021-2030)
• Table 22: Transcatheter Aortic Valve Replacement Devices Market in India (2021-2030)
• Table 23: Transcatheter Aortic Valve Replacement Devices Market in Australia (2021-2030)
• Table 24: Transcatheter Aortic Valve Replacement Devices Market in South Korea (2021-2030)
• Table 25: Transcatheter Aortic Valve Replacement Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 26: Transcatheter Aortic Valve Replacement Devices Market in the Rest of the World (2021-2030)
• Table 27: Transcatheter Aortic Valve Replacement Devices Market in the Middle East (2021-2030)
• Table 28: Transcatheter Aortic Valve Replacement Devices Market in Africa (2021-2030)
• Table 29: Transcatheter Aortic Valve Replacement Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Transcatheter Aortic Valve Replacement Devices Market in Global (2021-2030)
• Figure 3: Transcatheter Aortic Valve Replacement Devices Market in Global by Material (2021-2030)
• Figure 4: Transcatheter Aortic Valve Replacement Devices Market in Global by Procedure (2021-2030)
• Figure 5: Transcatheter Aortic Valve Replacement Devices Market in Global by Application (2021-2030)
• Figure 6: Transcatheter Aortic Valve Replacement Devices Market in Global by End-User (2021-2030)
• Figure 7: Transcatheter Aortic Valve Replacement Devices Market in Global by Geography (2021-2030)
• Figure 8: Transcatheter Aortic Valve Replacement Devices Market in North America (2021-2030)
• Figure 9: Transcatheter Aortic Valve Replacement Devices Market in the United States (2021-2030)
• Figure 10: Transcatheter Aortic Valve Replacement Devices Market in Canada (2021-2030)
• Figure 11: Transcatheter Aortic Valve Replacement Devices Market in Mexico (2021-2030)
• Figure 12: Transcatheter Aortic Valve Replacement Devices Market in Europe (2021-2030)
• Figure 13: Transcatheter Aortic Valve Replacement Devices Market in France (2021-2030)
• Figure 14: Transcatheter Aortic Valve Replacement Devices Market in Germany (2021-2030)
• Figure 15: Transcatheter Aortic Valve Replacement Devices Market in United Kingdom (2021-2030)
• Figure 16: Transcatheter Aortic Valve Replacement Devices Market in Italy (2021-2030)
• Figure 17: Transcatheter Aortic Valve Replacement Devices Market in Spain (2021-2030)
• Figure 18: Transcatheter Aortic Valve Replacement Devices Market in the Rest of Europe (2021-2030)
• Figure 19: Transcatheter Aortic Valve Replacement Devices Market in Asia-Pacific (2021-2030)
• Figure 20: Transcatheter Aortic Valve Replacement Devices Market in China (2021-2030)
• Figure 21: Transcatheter Aortic Valve Replacement Devices Market in Japan (2021-2030)
• Figure 22: Transcatheter Aortic Valve Replacement Devices Market in India (2021-2030)
• Figure 23: Transcatheter Aortic Valve Replacement Devices Market in Australia (2021-2030)
• Figure 24: Transcatheter Aortic Valve Replacement Devices Market in South Korea (2021-2030)
• Figure 25: Transcatheter Aortic Valve Replacement Devices Market in Rest of Asia-Pacific (2021-2030)
• Figure 26: Transcatheter Aortic Valve Replacement Devices Market in the Rest of the World (2021-2030)
• Figure 27: Transcatheter Aortic Valve Replacement Devices Market in the Middle East (2021-2030)
• Figure 28: Transcatheter Aortic Valve Replacement Devices Market in Africa (2021-2030)
• Figure 29: Transcatheter Aortic Valve Replacement Devices Market in South America (2021-2030)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 32: Marker Opportunities
• Figure 33: PORTER'S Five Force Analysis

Transcatheter Aortic Valve Replacement (TAVR) Devices Market by Material [Valve Frame Material (Nitinol, Stainless Steel, Cobalt Chromium, and Others), and Valve Leaflet Material (Porcine, Bovine and, Others)], Procedure (Transfemoral, Transapical and Transaortic Approach), Application (Aortic Stenosis, Aortic Regurgitation, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of chronic disorders and increasing product developmental activities worldwide

The transcatheter aortic valve replacement devices market was valued at USD 2.80 billion in 2023, growing at a CAGR of 15.41% during the forecast period from 2024 to 2030 to reach USD 6.60 billion by 2030. The transcatheter aortic valve replacement devices market is experiencing significant growth due to the increasing instances of chronic disorders such as aortic valve stenotic disease, aortic regurgitation, and mitral regurgitation, increasing product developmental activities including product launches, rising geriatric population, and others that are acting as major factors driving the substantial demand for transcatheter aortic valve replacement devices market from 2024 to 2030.

Transcatheter Aortic Valve Replacement Devices Market Dynamics:

The National Institute of Health (2022), stated that aortic valve stenotic disease was the most commonly occurring valvar pathology in developed nations, affecting 9 million people worldwide on an average, and its prevalence was increasing with aging population and the rise of atherosclerosis. Aortic regurgitation was associated with diastolic, but not systolic, hypertension, and it similarly saw an increase in developed countries. Mitral regurgitation affected 24 million people globally, with significant variability between and among nations.

TAVR devices are crucial in treating prevalent valvar diseases, especially aortic stenosis. As these conditions are often linked with aging and related health issues, TAVR offers a minimally invasive solution for high-risk patients who may not tolerate traditional surgery. By enabling effective valve replacement with shorter recovery times, TAVR addresses the growing need for accessible, advanced treatments for aortic and related valve pathologies in the face of an aging population and rising atherosclerosis rates.

Various product developmental strategies by the market key players such as introduction of new and innovative products are likely to push forward the revenue shares for the same. For example, in February 2024, Edwards Lifesciences Corporation announced launch of the Sapien 3 Ultra Resilia valve in Europe.

Hence, the interplay of all the above-mentioned factors is expected to drive the transcatheter aortic valve replacement devices market during the given forecast period from 2024 to 2030.

However, side effects such as bleeding, hematoma, or vascular injury, availability of alternative options, among others may restrict the market growth for the transcatheter aortic valve replacement devices market.

Transcatheter Aortic Valve Replacement Devices Market Segment Analysis:

Transcatheter Aortic Valve Replacement Devices Market by Material [Valve Frame Material (Nitinol, Stainless Steel, Cobalt Chromium, and Others), and Valve Leaflet Material (Porcine, Bovine and, Others)], Procedure (Transfemoral, Transapical and Transaortic Approach), Application (Aortic Stenosis, Aortic Regurgitation, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the procedure segment of the transcatheter aortic valve replacement devices market, the transfemoral category is expected to have a significant revenue share in the year 2023. The rapid growth of the transfemoral procedure for transcatheter aortic valve replacement is due to its widely utilized approach that offers several distinctive features and benefits, making it a preferred option for many patients with aortic valve stenosis.

One of the primary features of this technique is its minimally invasive nature, as it involves accessing the aorta through the femoral artery in the groin, which typically results in a smaller incision and less surgical trauma. This approach leads to significant benefits, including a shorter recovery time.

Additionally, advancements in imaging and device technology have improved the precision of valve placement during the procedure, leading to better overall results. The transfemoral approach is also beneficial for patients with favorable femoral artery anatomy, as it allows for straightforward access without the need for complex surgical interventions.

Therefore, owing to the above-mentioned factors, the demand for the transfemoral category upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the transcatheter aortic valve replacement devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall transcatheter aortic valve replacement devices market:

Among all the regions, North America is estimated to hold a significant revenue share in the transcatheter aortic valve replacement devices market. This is driven by the growing burden of aortic stenosis, regulatory support, prompt and well-established healthcare services and infrastructure, presence of key players, and other that are anticipated to significantly propel market growth for transcatheter aortic valve replacement devices in North America from 2024 to 2030.

According to data from the American Heart Association (2024), it stated that more that 20% of older Americans currently suffers from aortic stenosis. Same source further stated that it is more common in people of age 60 and above. Transcatheter aortic valve replacement devices are widely used to treat older individuals suffering from aortic stenosis. These offers minimally invasive alternative to traditional open-heart surgery. By replacing the narrowed aortic valve through a catheter-based procedure, this improves blood flow and heart function, helping these patients regain quality of life with reduced recovery time and fewer complications.

Various product developmental strategies such as clearances by the regulatory authorities in the region play a major role in pushing forward the revenue shares of transcatheter aortic valve replacement devices in the region. For example, in September 2021, Abbott announced that Food and Drug Administration approved the company's Portico(TM) with FlexNav(TM) transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery.

The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional transcatheter aortic valve replacement devices market. The presence of key players such as Medtronic, Boston Scientific Corporation, and Abbott with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the transcatheter aortic valve replacement devices market during the forecast period from 2024 to 2030.

Transcatheter Aortic Valve Replacement Devices Market key players:

Some of the key market players operating in the transcatheter aortic valve replacement devices market include Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, CryoLife, Inc., Braile Biomedica, Venus Medtech, Transcatheter Technologies Gmbh, Thubrikar Aortic Valve, Blue Sail Medical Co. Ltd., JC Medical Inc., Cook, Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, P+F Products + Features GmbH, and others.

Recent Developmental Activities in the Transcatheter Aortic Valve Replacement Devices Market:

• In August 2024, Boston Scientific Corporation announced that it secured CE mark for the ACURATE Prime(TM) Aortic Valve System, the newest transcatheter aortic valve replacement (TAVR) technology.
• In August 2021, Medtronic, announced the U.S. Food and Drug Administration approval of its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut(TM) FX TAVR system.
• In May 2021, Abbott announced that it received CE Mark for its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor(TM), making the minimally invasive device available for people in Europe with severe aortic stenosis who are at high or extreme surgical risk.

Key takeaways from the Transcatheter Aortic Valve Replacement Devices market report study

• Market size analysis for current transcatheter aortic valve replacement devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the transcatheter aortic valve replacement devices market
• Various opportunities available for the other competitors in the transcatheter aortic valve replacement devices market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current transcatheter aortic valve replacement devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for transcatheter aortic valve replacement devices market growth in the coming future?

Target audience who can be benefited from this Transcatheter Aortic Valve Replacement Devices market report study

• Transcatheter aortic valve replacement devices device providers
• Research organizations and consulting companies
• Transcatheter aortic valve replacement devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in transcatheter aortic valve replacement devices
• Various end-users who want to know more about the transcatheter aortic valve replacement devices market and the latest developments in the transcatheter aortic valve replacement devices market

Frequently Asked Questions for the Transcatheter Aortic Valve Replacement Devices Market:

1. What are Transcatheter Aortic Valve Replacement Devices?

• The transcatheter aortic valve replacement is a procedure wherein the diseased valve is replaced by an artificial, man-made valve. There are a number of man-made transcatheter aortic valves that are used while performing TAVR procedures. These include SAPIEN 3, SAPIEN 3 Ultra, Evolut PRO+, and LOTUS Edge.

2. What is the market for Transcatheter Aortic Valve Replacement Devices?

• The transcatheter aortic valve replacement devices market was valued at USD 2.80 billion in 2023, growing at a CAGR of 15.41% during the forecast period from 2024 to 2030 to reach USD 6.60 billion by 2030.

3. What are the drivers for the Transcatheter Aortic Valve Replacement Devices market?

• The transcatheter aortic valve replacement devices market is experiencing significant growth due to the increasing instances of chronic disorders such as aortic valve stenotic disease, aortic regurgitation, and mitral regurgitation, increasing product developmental activities including product launches, rising geriatric population, and others that are acting as major factors driving the substantial demand for transcatheter aortic valve replacement devices market from 2024 to 2030.

4. Who are the key players operating in the Transcatheter Aortic Valve Replacement Devices market?

• Some of the major market key players operating in the transcatheter aortic valve replacement devices market include Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, CryoLife, Inc., Braile Biomedica, Venus Medtech, Transcatheter Technologies Gmbh, Thubrikar Aortic Valve, Blue Sail Medical Co. Ltd., JC Medical Inc., Cook, Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, P+F Products + Features GmbH, and others.

5. Which region has the highest share in the Transcatheter Aortic Valve Replacement Devices market?

• Among all the regions, North America is estimated to hold a significant revenue share in the transcatheter aortic valve replacement devices market. This is driven by the growing burden of aortic stenosis, regulatory support, prompt and well-established healthcare services and infrastructure, presence of key players, and other that are anticipated to significantly propel market growth for transcatheter aortic valve replacement devices in North America from 2024 to 2030.

Table of Contents

1. Transcatheter Aortic Valve Replacement Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Transcatheter Aortic Valve Replacement Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Transcatheter Aortic Valve Replacement Devices Market Key Factors Analysis

• 5.1. Transcatheter Aortic Valve Replacement Devices Market Drivers
  • 5.1.1. Increasing instances of chronic disorders
  • 5.1.2. Increasing product developmental activities worldwide
  • 5.1.3. Rising geriatric population
• 5.2. Transcatheter Aortic Valve Replacement Devices Market Restraints and Challenges
  • 5.2.1. Side effects such as bleeding, hematoma, or vascular injury
  • 5.2.2. Availability of alternative options
• 5.3. Transcatheter Aortic Valve Replacement Devices Market Opportunities
  • 5.3.1. Development improved, durable and bio-prosthetic valves
  • 5.3.2. Integration of artificial intelligence (AI) and robotic assistance associated with precision

6. Transcatheter Aortic Valve Replacement Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Transcatheter Aortic Valve Replacement Devices Market Assessment

• 7.1. By Material
  • 7.1.1. Valve Frame material
    • 7.1.1.1. Nitinol
    • 7.1.1.2. Stainless Steel
    • 7.1.1.3. Cobalt-chromium
    • 7.1.1.4. Others
  • 7.1.2. Valve Leaflet Material
    • 7.1.2.1. Porcine
    • 7.1.2.2. Bovine
    • 7.1.2.3. Others
• 7.2. By Procedure
  • 7.2.1. Transfemoral Approach
  • 7.2.2. Transapical Approach
  • 7.2.3. Transaortic Approach
• 7.3. By Application
  • 7.3.1. Aortic Stenosis
  • 7.3.2. Aortic Regurgitation
  • 7.3.3. Others
• 7.4. By End-User
  • 7.4.1. Hospitals
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. United States Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.1.2. Canada Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.1.3. Mexico Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
  • 7.5.2. Europe
    • 7.5.2.1. France Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.2.2. Germany Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.2.3. United Kingdom Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.2.4. Italy Transcatheter Aortic Valve Replacement Devices market size in USD million (2021-2030)
    • 7.5.2.5. Spain Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.2.6. Rest of Europe Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. China Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.3.2. Japan Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.3.3. India Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.3.4. Australia Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.3.5. South Korea Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.3.6. Rest of Asia-Pacific Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. Middle East Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.4.2. Africa Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.4.3. South America Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)

8. Transcatheter Aortic Valve Replacement Devices Market Company and Product Profiles

• 8.1. Medtronic
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Edwards Lifesciences Corporation
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Boston Scientific Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Meril Life Sciences
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Abbott
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. JenaValve Technology, Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Bracco SpA
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. CryoLife, Inc.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Braile Biomedica
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Venus Medtech
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Transcatheter Technologies Gmbh
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Thubrikar Aortic Valve
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Blue Sail Medical Co. Ltd.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. JC Medical Inc.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Cook
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Sysmetis SA
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. SMT Pvt Ltd.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. LivaNova
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Peijia Medical
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. P+F Products + Features GmbH
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us